Rym Ben-Hamadi

Medicine · Health Sciences

13h-index991citations41works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(13), Mental Health Treatment and Access(11), Health Systems, Economic Evaluations, Quality of Life(8), Bipolar Disorder and Treatment(5), Workplace Health and Well-being(4)

Publications41 total

PCN249 Real World Treatment Patterns of Patients with Ovarian Cancer: Analysis of Targeted Therapies in the French National Claims Data
Value in Health·2021Open Access
Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
CNS Drugs·2012· 59 cited
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population.
PubMed·2012· 2 cited
Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors
Current Medical Research and Opinion·2011· 10 cited
Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder
Annals of Pharmacotherapy·2011· 18 cited
Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.
PubMed·2011· 4 citedOpen Access
Increased Olanzapine Discontinuation and Health Care Resource Utilization Following a Medicaid Policy Change
The Journal of Clinical Psychiatry·2011· 7 cited
Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs
Journal of Medical Economics·2011· 7 citedOpen Access
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study
Journal of Medical Economics·2010· 2 cited
Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons
Journal of Medical Economics·2010· 8 citedOpen Access
Assessing the Relationship Between Compliance With Antidepressant Therapy and Employer Costs Among Employees in the United States
Journal of Occupational and Environmental Medicine·2010· 17 cited
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance
Depression and Anxiety·2009· 386 cited
Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants
PharmacoEconomics·2009· 29 cited
PMH36 COMPARISON OF HOSPITALIZATIONS AND HEALTH CARE COSTS OF ELDERLY MAJOR DEPRESSIVE DISORDER (MDD) PATIENTS TREATED WITH ESCITALOPRAM, GENERIC SSRIS, OR SNRIS
Value in Health·2009Open Access
PMH33 ECONOMIC IMPLICATION OF DOSE ESCALATION IN DEPRESSED PATIENTS TREATED WITH ESCITALOPRAM OR VENLAFAXINE XR
Value in Health·2009Open Access
PMH38 THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI
Value in Health·2009· 1 citedOpen Access
PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT: SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
Value in Health·2009
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population
Current Medical Research and Opinion·2009· 16 cited
Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population
Value in Health·2009· 12 citedOpen Access
Assessing the Relationship Between Compliance with Antidepressant Therapy and Costs Among Employees in the United States
European Psychiatry·2009Open Access
page 1 of 3Next →

Frequent Co-authors

M. Haim Erder(13), Howard G. Birnbaum(12), Eric Q. Wu(12), Andrew P. Yu(11), RN(7), Matthew M. Hsieh(7), P Greenberg(6), AP Yu(6), HG Birnbaum(5), Jackson Tang(4), Karthik Ramakrishnan(4), MH Erder(4), D. Kelley(4), E.Q. Wu(4), EQ Wu(4), Ronald C. Kessler(3), David Kelley(3), Victoria Barghout(3), C Thibeault(3), Feride Frech(3)